NCT/Study#
NCT04104776 /
0209-01
A Phase 1/2 Study Of CPI-0209 Monotherapy And In Combination With Other Therapy In Patients With Advanced Tumors
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
